MOUNTAIN VIEW, Calif., Feb. 23, 2012 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its fourth quarter and full year 2011 financial results after the market closes on Thursday, March 1, 2012. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, March 1, 2012 to discuss the results of the quarter and full year and other business developments.
Interested parties may access the live conference call via telephone by dialing (800) 762-8779 U.S. or (480) 629-9771 (International) and quoting Conference ID 4517801, or by visiting the Company's website at http://www.iridex.com/. A telephone replay will be available beginning on Thursday, March 1, 2012 through Thursday, March 8, 2012 by dialing (800) 406-7325 (US) or (303) 590-3030 (International) and entering Access Code 4517801.
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com/.
SOURCE IRIDEX Corporation
Company, Jim Mackaness, Chief Financial Officer of IRIDEX, +1-650-940-4700; or Investor Relations, Matt Clawson of Allen & Caron, +1-949-474-4300, matt@allencaron.com, for IRIDEX
